We previously reported, significantly higher levels of Chymase and Tryptase in early stage plasma of DSS patients prior to the occurrence of shock suggesting a possible role of mast cells in dengue pathogenesis. To further investigate, we analyzed CMA1 promoter SNP (rs1800875) and TPSAB1 gene alleles, which encode the Human Chymase and a-and b-tryptase 1 enzymes respectively, for susceptibility to Dengue Hemorrhagic Fever (DHF) and Dengue Shock Syndrome (DSS) in patients from hospitals in Vietnam (Ho Chi Minh City and Vinh Long) and the Philippines. While the CMA1 promoter SNP (rs1800875) was not associated with DHF/DSS, the homozygous form of a-tryptase allele was associated with DSS patients in Vinh Long and the Philippines (OR = 3.52, p < 0.0001; OR = 3.37, p < 0.0001, respectively) and with DHF in Ho Chi Minh City (OR = 2.54, p = 0.0084). Also, a statistically significant association was observed when DHF and DSS were combined in Vinh Long (OR = 1.5, p = 0.034) and the Philippines (OR = 2.36, p = 0.0004); in Ho Chi Minh City when DHF and DSS were combine an association was observed, but it was not statistically significant (OR = 1.5, p = 0.0505). Therefore, the a-tryptase might have a possible effect on the susceptibility to severe form of Dengue infection. Ó
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Introduction
Dengue infection causes a wide spectrum of clinical presentation, from asymptomatic and mild Dengue fever (DF), to the most serious forms: Dengue Hemorrhagic Fever (DHF) and Dengue Shock Syndrome (DSS). It is a global emerging arboviral illness with the number of severe cases rapidly increasing about fivefold within the past 20 years. In Southeast Asian and Latin American countries, majority of the severe cases occur among the pediatric population [1] .
DHF is characterized by plasma leakage, thrombocytopenia, coagulation abnormalities, and/or haemorrhage while DSS is accompanied by hypovolemic shock. The pathogenesis of DSS/ DHF is not clear. Increased vascular permeability is generally recognized as the hallmark of these severe dengue forms. Currently, no targeted treatments exist to counterbalance the vascular leakage that occur during these severe complicated episodes, partly due to the lack of understanding of the mechanisms of Dengue virus (DV)-induced vascular leakage [2, 3] .
It has been suggested that increased vascular permeability, which has been implicated in the pathogenesis of asthma and other allergic diseases, is also responsible for the complications in severe Dengue infections. Mast cell activation is closely linked with local or systemic increases in vascular permeability in allergic diseases. Interestingly, recent studies in mouse models suggest that degranulation of mast cells are also involved in Dengue virus infection making them possible targets for novel therapeutic and preventive strategies [4] [5] [6] . Chymase and Tryptase are the major proteins specifically stored inside mast cells. They are secreted in the process of degranulation, which is a reflection of the magnitude of mast cell activation. These enzymes have indeed been reported to participate in the allergic process due to their vasoactive, proinflammatory and chemotactic actions [7] [8] [9] . We previously reported that on admission, plasma levels of Tryptase and Chymase are significantly elevated among DHF and/or DSS patients compared with either mild DF or febrile illness other than Dengue [10] . Moreover, in studies using mouse model and clinical human specimens with DHF and DSS, direct correlation between mast cell chymase production, and subsequent vascular leakage, were observed [4] .
Human Chymase is encoded in the CMA1 gene located on the long arm of chromosome 14 (14q11.2) . The polymorphism at the promoter region at À1903 G/A of the gene (rs1800875) has been analysed by several groups for its association with allergy and asthma [11] [12] [13] [14] . Human a-and b-tryptase are coded by two tandemly located genes TPSAB1 and TPSB2 on the chromosome 16 (16p.13.3). The TPSAB1 locus codes for the a-and b-tryptase 1, whereas the TPSB2 gene encodes functional isoforms b-tryptase 2 and b-tryptase 3 [15] [16] [17] . a-Tryptase is believed to be constitutive, largely inactive, not stored within the mast cell granules and therefore does not participate in the process of degranulation [19, 25] . It is the b-tryptase 1, on the other hand, is an active peptidase involved in the recruitment of neutrophils, initiation of mast cell degranulation and induction of microvascular leakage; hence, it is implicated as a key mediator of allergic inflammation and severity [18] [19] [20] . We compared the frequencies of the Chymase and Tryptase gene alleles (CMA1 and TPSAB1) in the patients with DHF or DSS and background healthy children using the DNA samples collected by two independent hospital based case control studies conducted 
Subjects and methods

Study subjects
Vietnamese subjects: The Patients were enrolled in the study previously reported [4] . Briefly, the case control study including healthy control children was performed at the Children's Hospital No. 2 in Ho Chi Minh City (HCMC) (n = 448) and the Center for Preventive Medicine in the Vinh Long Province (VL) (n = 513) during 2002 to 2005 in Vietnam. The inclusion criteria at the entry point in the hospital were age 6 months to 15 years old, Kinh ethnicity, and must not be related with each other. The patients were diagnosed with dengue using standard procedures for titration of anti-DV IgM and IgG antibodies, virus isolation, and RT-PCR for determination of viral. DV infection was defined by previously established serologic criteria for IgM/IgG Elisa's to DV (DEN 1-4) and Japanese encephalitis virus (kit from Pasteur Institute HCMC) in paired sera, collected in at least three days interval [27] . IgM/ IgG ELISAs were considered positive if the ratio of optical density (OD) of test sera to OD of negative control sera was P2.3 [28] . The cases were diagnosed as secondary infection when DV IgMto-IgG ratio was <1.8 [27] . Buffy coat samples were used to extract genomic DNA by using the QIAamp DNA blood kit (Qiagen, Germany). The 1998 WHO classification criteria [28] were applied to classify patients into DF, DHF and DSS. Our classification met the requirement of the simplified classification system of Integrated Management of Childhood Illness (IMCI), which is based on plasma leakage as a hallmark of severe dengue (DHF/DSS) [29] . 146 patients from Ho Chi Minh City and 218 from Vinh Long Providence were considered DSS patients, 107 patients and 97 were DHF patients, respectively. Vinh Long Providence have a higher percentage of secondary infection (65%) of 315 patients cases confirmed compare to 47% (120 patients) in 253 confirmed cases both DHF and DSS from Ho Chi Minh City.
Healthy unrelated school children living in HCMC (n = 195) and VL (n = 198), who had no symptoms of Dengue virus infection were recruited as a background population control group for the genetic study and titration of IgM were done according to the standard protocol for MAC-ELISA. In these control groups, 2 cases (1.02%) in HCMC and 13 cases (6.6%) in VL were seropositive by MAC-ELISA.
Philippine subjects: This study included children aged 5- [28] was likewise used to classify the Dengue severity. Patients who went into shock (DSS cases) accounted for majority of the patients (121% or 77.6%), while DHF cases were 34 patients. Most of the confirmed cases both DHF and DSS had secondary infection (123% or 80%).
Unrelated children from a community in Quezon City and a meningococcemia vaccine efficacy study in Muntinlupa City formed the background population group (n = 268), which sera were tested for Dengue IgG antibodies using the PanBio Dengue IgG Capture Antibody test by ELISA (Inverness Medical Innovations, Queensland, Australia) and 10 cases (4%) were seropositive for IgG antibodies.
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CMA1: the promoter region of CMA1 at position À1903G/A substitution
Genomic DNA was extracted from EDTA-Blood and stored at À20°C as described elsewhere [30] . The promoter region of CMA1 at position À1903 G/A substitution (rs1800875) was investigated using primer pairs: CMA1 Forward Primer: 5 0 -GGA-AATGTGAGCAGATAGCGCAGTC-3 0 and CMA1 Reverse Primer: 5 0 -AATCCGGAGCTGGAGAACTCTTGTC-3 0 . Polymerase chain reaction (PCR) amplifications were performed in a final volume of 30 ll using 10 pmol/ll of forward and reverse primer (CMA1PF, CMA1PR), 10X buffer with 25 mM containing MgCl 2 , 2.5 mM of dNTPs, 10 ng DNA template and 2 unit of Takara Ex Taq enzyme (Takara Bio. Inc., Shiga, Japan). PCR amplification was then performed for these specimens using Thermal cycler (Biometra, Fr) programmed for 94°C for 5 min as initial denaturation, 34 cycles of 15 s at 94°C for denaturation, 60°C annealing for 15 s, 15 s extension at 72°C, and a final extension for 10 min at 72°C. The product from PCR was confirmed by 2% agarose gel electrophoresis. The restriction cutting of CMA1 gene promoter region at position À1903 for alternative allele G/A substitution was used for restriction fragments length polymorphisms (RFLP) method. The Amplified DNA fragments were genotyped by restriction digestion with enzyme BstXI (New England Biolabs, MA, USA). Digested fragments were determined by electrophoresis using 2% agarose gels, stained with ethidium bromide, and visualizing with UV trans-illuminator. RFLP genotype of individuals were typed in the GG genotype (283 bp, À1903G homozygote), AA genotype (189/94 bp, À1903A homozygote) and the AG heterozygous (283/189/94 bp, À1903A/G).
The accuracy of the RFLP genotype was confirmed by direct sequencing of control samples from Ho Chi Minh City and Vinh Long Providence. To eliminate excess primers and dNTPs, cleaning up of the PCR products was performed using 2 ll of EXOSAP-IT (Ubp, USA) incubated at 37°C for 15 minutes and then inactivated by heating at 80°C for 15 min. The sequencing reaction mixture containing 3 ng of Exosap treated PCR amplicon, 2.0 ll of Big Dye V1.1, 5Â sequencing buffer, 2 ll of primer (0.8 pmol/ll) and 0.25 ll of Big Dye Terminator V1.1 (Life Technologies, Co., USA) was prepared to a final volume of 10 ll. The sequencing reaction was performed using a Thermal cycler (Biometra, Fr) under the following conditions: 25 cycles of [96°C for 10 s, 50°C for 5 s, 60°C for 4 min].The extension products were then purified by gel filtration using Sephadex G-50 (Qiagen, Ger) and sequenced in an ABI 3730 Genetic Analyzer (Life Technologies Co., USA). Finally, sequencing data were analyzed with Sequence Analysis software DNAdynamo (BlueTractorSoftware Ltd). . PCR mixtures containing 10 pmol/ll of forward and reverse primer (TPSAB1PF-FAM, TPSAB1PR), 10Â buffer with 25 mM containing MgCl 2 , 2.5 mM of dNTPs, 10 ng DNA template and 2 unit of Takara Ex Taq enzyme (Takara Bio. Inc., Shiga, Japan) were prepared to a final volume of 30 ll. PCR was then performed using Thermal cycler (Biometra, Fr) programmed for 95°C for 1 min for initial denaturation; 30 s at 95°C for denaturation, 66°C annealing for 45 s, and 45 s extension at 72°C for 30 cycles; and a final extension for 10 min at 72°C. Visualization for confirmation of PCR amplification products was done 2% agarose gel electrophoresis with an expected fragment size of 138 bp. Amplified DNA fragments were then diluted 1:10 with double distilled water, and mixed with 100Â diluted 500 ROX size standard marker (Life Technologies, Co., USA) and Hi-Di Formamide buffer (Life Technologies, Co., USA). These were then heated to 95°C for 3 min for denaturation and immediately cooled down in an ice bath for 5 min. The samples were processed using the sequencer ABI 3730 Genetic Analyzer (Life Technologies Co., USA) and analyzed with the Gene Mapper Analysis software (Applied Biosystems). The measures of fragment length were used for allele calling.
Statistical analysis
Hardy-Weinberg equilibrium, linkage disequilibrium (LD), and haplotype analysis were calculated using PyPopWin32.0.7.0 software (University of Berkely, Berkely, CA) [32] . The strength of association of the given genetic factors with disease severity was assessed using odds ratio (OR) and the significance of association was evaluated by two-sided Fisher's exact test using StatsDirect statistical software (ver.2.8.0, Stats direct Ltd. UK).
Results
Gene frequency of the SNP at position À1903 G/A of the promoter region of Chymase gene (CMA1)
For CMA1 gene À1903 G/A SNP (rs1800875), the distribution of A and G alleles was not found to be significantly different between cases and controls in both populations from Vietnamese and the Philippines ( Table 1 ). The genotype frequencies fit to the HardyWeinberg equilibrium in the total subjects. Direct sequencing of the PCR products from 180 control samples from Vietnam confirmed the amplification of the target promoter region containing the expected BstXI restriction site at position À1903. The gene frequency of the a-tryptase in Vietnam and the Philippines, was fitted to the Hardy-Weinberg equilibrium ( Table 2 ).
As shown in Table 3 , the a allele in homozygous form was significantly associated with the development of DHF compared with healthy controls (OR = 2.54, p = 0.0084) at HCMC. Development of DSS was significantly associated with the homozygous a-allele compared with healthy controls in patients from VL and the Philippines (OR = 3.52, p < 0.0001 and OR = 3.37, p < 0.0001, respectively), furthermore when immune response was consider, those with secondary infection and confirmed DSS have a significant increase of susceptibility compare with healthy controls (VL; OR = 4.44, p < 0.0001 and the Philippines; OR: 3.77. p < 0.0001). When the group of DSS and DHF patients were combined and compared with healthy controls, association of these severe forms with the a allele was noted to be significant in patients from VL and the Philippines (OR = 2.63, p = 0.0001 and OR = 3.06, p = <0.0001 respectively); however, this association did not reach statistical significance among HCMC subjects (OR = 1.64; p = 0.11). A similar tendency for association was observed when the dominant a allele contribution model was used to compare those with severe forms of Dengue with healthy controls in HCMC, VL and the Philippines (Table 3) .
Discussion
Our study showed no significant association between CMA1 À1903G allele and Dengue severity. Several studies have looked into the association of this allele with allergic diseases. A positive association between CMA1 À1903G allele and Japanese patients with atopic eczema, but not in those with asthma, atopic dermatitis or rhinitis, has been reported [21, 22] . The same allele was also associated with total serum levels of IgE (<500 IU/mL) among atopic eczema patients [23] . In an Egyptian study, this allele was associated with asthmatic children [14] . On the other hand, no significant association of this allele was observed in several studies among Caucasian patients with asthma and atopic dermatitis [11] [12] [13] . Such inconsistent results suggest that CMA1 À1903 G/A SNP (rs1800875) may not be a strong marker for susceptibility to allergic diseases. Similarly, the results of our study seem to show that this allele is less likely to play a major role in the progression to and pathogenesis of severe dengue infections. Although chymase levels have been found to be elevated in the serum of severe dengue patients [10] , this increase may not be attributable to the genotypes of the SNP studied or other mechanisms in transcription, translation and gene expression regulation might be responsible.
Because we found a significant association between severe forms of Dengue fever and the homozygous a-tryptase allele of the TPSAB1 gene as shown in Table 3 , the expression of a-tryptase in mast cells or in basophils [24] is suspected to affect susceptibility to DHF and DSS. a-and b-tryptase are soluble proteases, and proteolytic activation leads them to assemble into a mature tetrameric form and storage in mast cell granules, however it has been considered this process occurs with b-tryptase and confine to atryptase, which is continuously secreted, as a result of a deletion in the TPSAB1 gene [9, 19] . In our previous study, using the same plasma samples from Vietnamese patients, plasma levels of tryptase increased significantly in DHF and DSS thus suggesting that degranulation of mast cells is a key process in the pathogenesis of severe Dengue [10] . Note, however, that the tryptase in serum, whose levels had been found to be elevated in that study, included both a-tryptase and ß-tryptase. Our present observation of increased susceptibility to severe dengue in those with the homozygous form of a-tryptase allele might suggest that expression of this allele might not be constitutive as previously believed. The elevation in total serum plasma, believed to be largely b-tryptase mediated, may in fact be attributable to the effects of a-tryptase. In a study involving Caucasian families with at least two asthmatic siblings (per family) reported a significant association of a-tryptase allele and the disease severity in asthma [25] . This study also reported that more than one copy of a alleles may be present in one gene and that the presence of more copies are associated with increased atopy severity. Similarly, a study involving healthy subjects reported significantly higher levels of plasma tryptase in those with genotypes having at least one a-tryptase allele than in those without [26] . Taken together, a-tryptase allele may contribute to the degree of vascular leakage, and consequently to the severity of a disease via mechanisms that are still not well elucidated. This may possibly be related to the plasma levels of a-tryptase or that a-tryptase might be a competitive inhibitor to b-tryptase tetramerization inside the granules in the setting of severe dengue. At this point, we are not able to demonstrate the plasma levels of a-tryptase. However, the finding of the strong effect of homozygous a-tryptase on the pathogenesis of DHF and DSS encourages further investigation of the mast cell activation mechanism during the acute phase of dengue infection. With previous studies reporting a significant association of the a-allele with atopy, it would be important to elicit the history of atopy or any allergic conditions and rule them out as a potential, confounding factor.
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